Cellerix Overview
- Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
67
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$79.7M
Cellerix General Information
Description
Developer of medicinal products. The company's products are used for the treatment of gastroenterology, dermatology and immune-based diseases.
Contact Information
Primary Office
- Madrid
- Spain
Cellerix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 05-May-2011 | $79.7M | 00000 | 000.00 | Completed | Generating Revenue |
| 4. Debt - General | 00000 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 28-Jan-2010 | 000.00 | 00000 | Completed | Generating Revenue | |
| 2. Early Stage VC | 11-Nov-2009 | $40.2M | $71.1M | Completed | Startup | |
| 1. Early Stage VC | 01-Sep-2007 | $30.9M | $30.9M | Completed | Startup |
Cellerix Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cellerix Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| EQT Life Sciences | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Genetrix Group | Corporation | Minority | 000 0000 | 000000 0 | |
| Novartis Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Roche Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Ventech | Venture Capital | Minority | 000 0000 | 000000 0 |